Joanne Goodman

1.5k total citations · 1 hit paper
22 papers, 1.0k citations indexed

About

Joanne Goodman is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Joanne Goodman has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 12 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Joanne Goodman's work include Biosimilars and Bioanalytical Methods (14 papers), Advanced Biosensing Techniques and Applications (8 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Joanne Goodman is often cited by papers focused on Biosimilars and Bioanalytical Methods (14 papers), Advanced Biosensing Techniques and Applications (8 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Joanne Goodman collaborates with scholars based in United Kingdom, Denmark and United States. Joanne Goodman's co-authors include Jonathan Tran, Michael A. Watson, Bryan Laffitte, Xuping Wang, Elaine McKilligin, Ronald E. Law, Alan R. Collins, Mingyi Chen, Timothy M. Willson and Liming Pei and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Lipid Research and Frontiers in Immunology.

In The Last Decade

Joanne Goodman

22 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synthetic LXR ligand inhibits the development of atherosclerosis in mice

2002 778 citations Sean B. Joseph, Elaine McKilligin et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joanne Goodman United Kingdom	11	659	538	326	267	170	22	1.0k
Françoise Caira France	17	417 0.6×	481 0.9×	321 1.0×	92 0.3×	196 1.2×	31	1.0k
Federica Basso United States	13	545 0.8×	314 0.6×	302 0.9×	177 0.7×	152 0.9×	20	941
Kristin L. Gillotte United States	10	454 0.7×	398 0.7×	119 0.4×	241 0.9×	108 0.6×	11	887
Matthew K. Howe United States	8	350 0.5×	524 1.0×	229 0.7×	106 0.4×	490 2.9×	8	1.0k
Toshifumi Ito Japan	18	339 0.5×	653 1.2×	280 0.9×	159 0.6×	95 0.6×	44	1.2k
Margarita de la Llera Moya United States	10	1.1k 1.6×	627 1.2×	275 0.8×	185 0.7×	315 1.9×	13	1.6k
David J. Bonnet United States	18	393 0.6×	435 0.8×	150 0.5×	481 1.8×	434 2.6×	22	1.3k
L Chan United States	18	345 0.5×	765 1.4×	103 0.3×	238 0.9×	233 1.4×	25	1.4k
Ilia V. Fuki United States	20	803 1.2×	747 1.4×	279 0.9×	173 0.6×	396 2.3×	27	1.7k
Jean‐Marc Herbert France	18	250 0.4×	403 0.7×	94 0.3×	114 0.4×	199 1.2×	37	1.2k

Countries citing papers authored by Joanne Goodman

Since Specialization

Citations

This map shows the geographic impact of Joanne Goodman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne Goodman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne Goodman more than expected).

Fields of papers citing papers by Joanne Goodman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne Goodman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne Goodman. The network helps show where Joanne Goodman may publish in the future.

Co-authorship network of co-authors of Joanne Goodman

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne Goodman. A scholar is included among the top collaborators of Joanne Goodman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne Goodman. Joanne Goodman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cowan, Kyra J., D. C. Dyer, Morten Carlsen, et al.. (2024). The European Bioanalysis Forum recommendation on establishing appropriate drug tolerance levels in antidrug antibody assays. Bioanalysis. 16(17-18). 915–921. 3 indexed citations

Vavere, Andrea L., Marvin Sinsakul, Emily L. Ongstad, et al.. (2023). Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results. Journal of the American Heart Association. 12(3). e027540–e027540. 14 indexed citations

Stebbings, Richard, Christopher R. Jones, Joanne Goodman, et al.. (2022). SARS-CoV-2 Spike Protein Expression In Vitro and Hematologic Effects in Mice Vaccinated With AZD1222 (ChAdOx1 nCoV-19). Frontiers in Immunology. 13. 836492–836492. 7 indexed citations

Stebbings, Richard, et al.. (2021). Developmental and reproductive safety of AZD1222 (ChAdOx1 nCoV-19) in mice. Reproductive Toxicology. 104. 134–142. 17 indexed citations

Stebbings, Richard, et al.. (2021). AZD1222 (ChAdOx1 nCov-19): A Single-Dose biodistribution study in mice. Vaccine. 40(2). 192–195. 9 indexed citations

Goodman, Joanne, Jonas Blaes, John Cook, et al.. (2021). A Strategic Approach to Nonclinical Immunogenicity Assessment: A Recommendation from the European Bioanalysis Forum. Bioanalysis. 13(7). 537–549. 12 indexed citations

Timmerman, Philip, Matthew Barfield, Kyra J. Cowan, et al.. (2021). Recommendations and Discussion Points on Immunogenicity, Biomarkers, Automation/Technology and Protein–MS From the 2021 European Bioanalysis Forum Focus Workshops. Bioanalysis. 13(19). 1459–1465. 2 indexed citations

Lainé, Anne-Laure, Anders Broo, Ian Jones, et al.. (2020). Developing an injectable co-formulation of two antidiabetic drugs: Excipient impact on peptide aggregation and pharmacokinetic properties. International Journal of Pharmaceutics. 576. 119019–119019. 8 indexed citations

Timmerman, Philip, Joanne Goodman, Michaela Golob, et al.. (2020). European Bioanalysis Forum Feedback on Draft ICH M10 Guideline on Bioanalytical Method Validation During the Step 2b Public Consultation Period. Bioanalysis. 12(sup6). 1–11. 8 indexed citations

10.

Goodman, Joanne, Kyra J. Cowan, Michaela Golob, et al.. (2020). Update to the European Bioanalysis Forum Recommendation on Biomarkers Assays; Bringing Context of Use Into Practice. Bioanalysis. 12(20). 1427–1437. 15 indexed citations

11.

Barfield, Matthew, et al.. (2020). European Bioanalysis Forum Recommendation on Singlicate Analysis for Ligand Binding Assays: Time for a New Mindset. Bioanalysis. 12(5). 273–284. 10 indexed citations

12.

Pihl, Susanne, et al.. (2019). EBF Recommendation on Practical Management of Critical Reagents for Antidrug Antibody Ligand-Binding Assays. Bioanalysis. 11(19). 1787–1798. 14 indexed citations

13.

Pihl, Susanne, et al.. (2018). EBF Recommendation on Practical Management of Critical Reagents for PK Ligand-Binding Assays. Bioanalysis. 10(19). 1557–1565. 12 indexed citations

14.

Goodman, Joanne, Simon Cowen, Viswanath Devanarayan, et al.. (2018). Feedback from the European Bioanalysis Forum: Focus Workshop on Current Analysis of Immunogenicity: Best Practices and Regulatory Hurdles. Bioanalysis. 10(4). 197–204. 9 indexed citations

15.

Timmerman, Philip, Michaela Golob, Joanne Goodman, et al.. (2018). Toward Decision-Based Acceptance Criteria for Bioanalytical Method Validation: A Proposal for Discussion from the European Bioanalysis Forum. Bioanalysis. 10(16). 1255–1259. 11 indexed citations

16.

Kunz, Ulrich, Joanne Goodman, Timo Piironen, et al.. (2017). Addressing The Challenges of Biomarker Calibration Standards in Ligand-Binding Assays: A European Bioanalysis Forum Perspective. Bioanalysis. 9(19). 1493–1508. 8 indexed citations

17.

Sprecher, Dennis L., et al.. (2015). Discovery and characterization of GSK256073, a non-flushing hydroxy-carboxylic acid receptor 2 (HCA2) agonist. European Journal of Pharmacology. 756. 1–7. 21 indexed citations

18.

Goodman, Joanne & Balaji Agoram. (2013). Analytical Assay Platforms for Soluble Target Engagement Biomarkers: Old Favorites and Emerging Technologies. Bioanalysis. 5(23). 2919–2931. 10 indexed citations

19.

Joseph, Sean B., Elaine McKilligin, Liming Pei, et al.. (2002). Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proceedings of the National Academy of Sciences. 99(11). 7604–7609. 778 indexed citations breakdown →

20.

Mersmann, H. J., Joanne Goodman, & Laurie Brown. (1975). Development of swine adipose tissue: morphology and chemical composition. Journal of Lipid Research. 16(4). 269–279. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact